NPS RADAR August 2005
||Why read this
|Angiotensin II receptor antagonists: unrestricted PBS listing
||Reviews new unrestricted PBS listing of candesartan, eprosartan, irbesartan, and telmisartan for hypertension, heart failure, and diabetic nephropathy.
|Ciclesonide (Alvesco) inhaler for asthma
||Reviews use of ciclesonide inhaler for asthma, with emphasis on titration to minimum dose.
|Methylphenidate (Ritalin) for attention deficit hyperactivity disorder
||Reviews use of methylphenidate for attention deficit hyperactivity disorder, including drug control issues and combination with non-drug interventions.
|Elevated cardiovascular risk with NSAIDs?
||Reviews evidence of elevated cardiovascular risk associated with COX-2 selective NSAIDs and provides guidelines for NSAID use and risk assessment.
|NPS RADAR August 2005
||NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.